Cardinal Capital Management increased its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 15.5% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 9,180 shares of the medical instruments supplier’s stock after buying an additional 1,235 shares during the period. Cardinal Capital Management owned approximately 0.25% of Utah Medical Products worth $665,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the stock. Strs Ohio raised its position in shares of Utah Medical Products by 8.0% in the second quarter. Strs Ohio now owns 2,700 shares of the medical instruments supplier’s stock worth $195,000 after buying an additional 200 shares in the last quarter. Janney Montgomery Scott LLC raised its position in shares of Utah Medical Products by 9.3% in the second quarter. Janney Montgomery Scott LLC now owns 3,947 shares of the medical instruments supplier’s stock worth $286,000 after buying an additional 335 shares in the last quarter. Spark Investment Management LLC purchased a new position in shares of Utah Medical Products during the second quarter worth approximately $325,000. Finally, Russell Investments Group Ltd. raised its position in shares of Utah Medical Products by 19.1% in the second quarter. Russell Investments Group Ltd. now owns 47,619 shares of the medical instruments supplier’s stock worth $3,448,000 after buying an additional 7,649 shares in the last quarter. Institutional investors and hedge funds own 65.51% of the company’s stock.
Shares of Utah Medical Products, Inc. (UTMD) traded down 3.62% during trading on Friday, hitting $69.30. The stock had a trading volume of 11,319 shares. The company has a market capitalization of $257.73 million, a PE ratio of 19.87 and a beta of 0.74. The firm has a 50-day moving average price of $71.40 and a 200 day moving average price of $65.46. Utah Medical Products, Inc. has a 52 week low of $56.30 and a 52 week high of $75.00.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be issued a $0.265 dividend. This represents a $1.06 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 14th. Utah Medical Products’s payout ratio is 30.37%.
COPYRIGHT VIOLATION WARNING: “Cardinal Capital Management Acquires 1,235 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)” was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at https://stocknewstimes.com/2017/08/13/utah-medical-products-inc-nasdaqutmd-stake-boosted-by-cardinal-capital-management-updated.html.
Several analysts have recently issued reports on the company. BidaskClub downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. ValuEngine upgraded Utah Medical Products from a “sell” rating to a “hold” rating in a research report on Tuesday, June 6th.
Utah Medical Products Company Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
